FDA Approves Unknown Drug — RISING
RISING announced today that the FDA has approved its ANDA, a regulatory milestone that the company expects will bolster its financial performance and generate near-term revenue gro…
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
RISING announced today that the FDA has approved its ANDA, a regulatory milestone that the company expects will bolster its financial performance and generate near-term revenue gro…
**USAntibiotics, LLC** has secured FDA clearance for Augmentin ES-600 (amoxicillin and clavulanate potassium), reinforcing the company's position in the pediatric antibiotics marke…
SpecGx LLC has secured an FDA approval for the generic version of Acetaminophen and Codeine Phosphate oral tablets, expected to expand its current portfolio and enhance its footpri…
# FDA Approves Teva Women's Health's Oral Methotrexate Sodium Product Teva Women's Health LLC received FDA approval for TREXALL (methotrexate sodium) oral formulation, expanding t…
On December 19, 2000, Rising received FDA approval for ANDA075725, marking a significant commercial entry into the market. This approval is expected to bolster the company’s revenu…
# FDA Approves Doxycycline ANDA for Strides Pharma Science Limited Strides Pharma Science Limited has received FDA approval for its abbreviated new drug application (ANDA065055) f…
# FDA Approval Newswire Kenvue Brands LLC has received FDA approval for IMODIUM Multi-Symptom Relief, an oral combination formulation of loperamide hydrochloride and dimethicone, …
# FDA Approves Fresenius Medical Care's Venofer for Intravenous Iron Supplementation Fresenius Medical Care Holdings, Inc. received FDA approval for Venofer (iron sucrose), an int…
# FDA Approves Generic Leuprolide Acetate for Meitheal Pharmaceuticals Meitheal Pharmaceuticals Inc received FDA approval for its generic leuprolide acetate injection (ANDA075471)…
SpecGx LLC announced Monday that its ANDA040409 application for hydrocodone bitartrate and acetaminophen tablets was granted final approval. This move expands generic competition i…
Aurobindo Pharma Limited announced the approval of an Abbreviated New Drug Application for doxazosin mesylate tablets to be marketed immediately. This expansion into the oral gener…
Advagen Pharma Ltd obtained FDA approval on October 6, 2000, for its generic oral Clonazepam tablet under ANDA075468. The clearance is expected to bolster Advagen’s earnings potent…
SpecGx LLC secured FDA approval for filing ANDA040405, gaining market access for generic HYDROCODONE BITARTRATE AND ACETAMINOPHEN. The entry of this generic alternative is expected…
AbbVie Inc. solidified its foothold in the anticonvulsant market with the FDA approval of DEPAKOTE ER, the once-daily extended-release version of divalproex sodium, which is positi…
# FDA Approves Haleon's ABREVA (Docosanol) for Cold Sore Treatment Haleon US Holdings LLC has received FDA approval for ABREVA (docosanol), a topical antiviral treatment for cold …
Sandoz today received FDA approval for the unspecified substance designated under NDA020883 on June 30, 2000; although the specific therapeutic attribute remains unidentified in th…
STRIDES PHARMA INTL secured FDA approval for its generic submission, a milestone anticipated to intensify price competition and drive market share gains against branded incumbents.
**Pharmacia & Upjohn Company LLC** has secured FDA approval for its generic linezolid tablets, marking the first oral treatment for Staphylococcus aureus. This important clearance …
Sun Pharmaceutical Industries, Inc. secured FDA approval for the generic version of PENTAZOCINE AND NALOXONE, a strategic addition anticipated to boost the company’s revenue potent…
Mylan Pharmaceuticals received FDA approval for a transdermal estradiol patch, a move likely to intensify competitive pricing pressures and potentially erode the market share of br…